“…In this regard, animal studies have demonstrated neuroprotective effects of: (1) infusion of BDNF into the brain (Beck et al, 1994; Novikova et al, 2000; Nomura et al, 2005); (2) viral vector-mediated delivery of the BDNF gene into neurons (Bemelmans et al, 2006; Nosheny et al, 2007; Nagahara et al, 2009); (3) transplantation of cells genetically engineered to overexpress BDNF (Frim et al, 1994; Liu et al, 1999; Nomura et al, 2005); (4) administration of chemicals that stimulate neurons to produce BDNF (Hou et al, 2010; Xu et al, 2011; Fass et al, 2012); and (5) treatment with chemicals that activate trkB (Lee and Chao, 2001; Massa et al, 2010; Devi and Ohno, 2012; Schmid et al, 2012). Drugs in one class of widely prescribed anti-depressants, the serotonin- and norepinephrine reuptake inhibitors, are believed to exert their clinical benefit by up-regulating BDNF production (Xu et al, 2003, 2006; De Foubert et al, 2004; Russo-Neustadt et al, 2004; Yoshimura et al, 2007).…”